Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Innovent doses first patient in Phase III trial of tyvyt for ESCC

CT scan showing an esophageal tumour. Credit: Tdvorak.



  • Innovent Biologics

Go Top